“…TCM, with a long history of treating various diseases through modulating the human immune response, offers a potential to be a remedy of the new immunomodulating regimen for cancer treatment. They exert broad immunostimulatory activities by recruiting and activating different types of immune cells, such as dendritic cells (DC), natural killer (NK) T-cells, T cells, macrophage, monocytes (54)(55)(56) and adjusting the production of cytokines (IFN-α, IL-2, IL-6 and IFN-γ) (54,57,58) to fight against the tumor cells.…”